Home / News / India News / Article /
Moderna seeks regulatory approval from DCGI for its Covid-19 vaccine
Updated On: 29 June, 2021 12:00 AM IST | New Delhi | PTI
Mumbai-based pharmaceutical firm Cipla, on behalf of the US pharma major, has requested for import and marketing authorisation of these jabs

Photo for representational purpose. Pic/ AFP
India's drug regulator may soon grant restricted emergency use authorisation for Moderna's Covid-19 vaccine, official sources said on Tuesday.
Moderna has also informed that the US Government has agreed to donate a certain number of doses of the Moderna Covid-19 vaccine through COVAX to the Government of India for use and has sought approval from the Central Drugs Standard Control Organisation (CDSCO) for these vaccines.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.



